Recent clinical trials of immunotherapy in non-small-cell lung cancer

被引：7
|
作者：
Gkolfinopoulos, Stavros [1 ]
Mountzios, Giannis [2 ]
机构：
[1] BOC Oncol Ctr, Med Oncol Dept, CY-2006 Nicosia, Cyprus
[2] Henry Dunant Hosp Ctr, Med Oncol Dept 2, Athens 11526, Greece
来源：
IMMUNOTHERAPY | 2019年 / 11卷 / 06期
关键词：
atezolizumab; avelumab; checkpoint inhibitors; durvalumab; ipilimumab; nivolumab; non-small-cell lung cancer; pembrolizumab; DOCETAXEL; NIVOLUMAB; INTERLEUKIN-2; ATEZOLIZUMAB; BURDEN;
D O I：
10.2217/imt-2019-0021
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：461 / 466
页数：6
相关论文
共 50 条
  • [21] Neoadjuvant immunotherapy in resectable non-small-cell lung cancer
    Chen, Lanyi Nora
    Wei, Alexander Z.
    Shu, Catherine A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [22] Immunotherapy for non-small-cell lung cancer: current approaches
    Elisabeth Quoix
    Jean Marc Limacher
    Current Respiratory Care Reports, 2014, 3 (1): : 19 - 25
  • [23] Immunotherapy for non-small-cell lung cancer: current approaches
    Quoix, Elisabeth
    Limacher, Jean Marc
    CURRENT PULMONOLOGY REPORTS, 2014, 3 (01) : 19 - 25
  • [24] Immunotherapy in non-small-cell lung cancer: a bridge between research and clinical practice
    Francesco, Passiglia
    Oriana, Commendatore
    Milena, Vitali
    Raffaele, Conca
    FUTURE ONCOLOGY, 2018, 14 (13) : 41 - 60
  • [25] Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies
    Zhou, Suna
    Yang, Haihua
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [26] Non-small-cell lung carcinoma vaccines in clinical trials
    Rossi, Antonio
    Maione, Paolo
    Schettino, Clorinda
    Bareschino, Maria Anna
    Sacco, Paola Claudia
    Ambrosio, Rita
    Barbato, Valentina
    Zeppa, Rosario
    Palazzolo, Giovanni
    Gridelli, Cesare
    EXPERT REVIEW OF VACCINES, 2011, 10 (06) : 887 - 897
  • [27] Immunotherapy for non-small cell lung cancer: current concepts and clinical trials
    Mayor, Marissa
    Yang, Neng
    Sterman, Daniel
    Jones, David R.
    Adusumilli, Prasad S.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (05) : 1324 - 1333
  • [28] More power to trials for non-small-cell lung cancer
    Sorensen, JB
    Hansen, HH
    ANNALS OF ONCOLOGY, 1996, 7 (02) : 119 - 120
  • [29] Clinical Trials of Vascular Disrupting Agents in Advanced Non-Small-Cell Lung Cancer
    McKeage, Mark J.
    CLINICAL LUNG CANCER, 2011, 12 (03) : 143 - 147
  • [30] Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer
    Giri, Anshu
    Walia, Simrit S.
    Gajra, Ajeet
    REVIEWS ON RECENT CLINICAL TRIALS, 2016, 11 (04) : 297 - 305
12345